Ovid Therapeutics Ownership | Who Owns Ovid Therapeutics?


OverviewForecastRevenueFinancialsChart

Ovid Therapeutics Ownership Summary


Ovid Therapeutics is owned by 14.29% institutional investors, 15.90% insiders, and 69.81% retail investors. Takeda pharmaceutical is the largest institutional shareholder, holding 10.61% of OVID shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.52% of its assets in Ovid Therapeutics shares.

OVID Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockOvid Therapeutics14.29%15.90%69.81%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Takeda pharmaceutical7.53M10.61%$7.01M
Rubric capital management lp5.32M7.49%$4.96M
Blackrock3.99M5.65%$3.07M
Blackrock funding, inc. /de3.93M5.54%$3.67M
Bvf inc/il3.85M5.43%$3.60M
Madison avenue partners, lp3.72M5.24%$3.48M
Vanguard group3.15M4.44%$2.94M
Siren2.85M4.02%$2.66M
Artal group2.50M3.54%$1.92M
Acadian asset management1.85M2.61%$1.73M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Takeda pharmaceutical7.53M26.40%$7.01M
Tls advisors680.97K1.45%$636.00K
Madison avenue partners, lp3.72M0.37%$3.48M
Sio capital management1.00M0.26%$933.70K
Bvf inc/il3.85M0.12%$3.60M
Siren2.85M0.12%$2.66M
Ubs oconnor943.42K0.07%$881.15K
Rubric capital management lp5.32M0.06%$4.96M
Velan capital investment management lp70.00K0.06%$65.36K
Artal group2.50M0.05%$1.92M

Top Buyers

HolderShares% AssetsChange
Driehaus capital management1.40M0.01%1.40M
Adage capital partners gp1.00M0.00%1.00M
Sio capital management1.00M0.26%1.00M
Ubs oconnor943.42K0.07%315.13K
State street1.35M-198.72K

Top Sellers

HolderShares% AssetsChange
Ecor1 capital---6.12M
Blue owl capital lp---864.82K
Prosight management, lp---729.21K
Fft wealth management---489.55K
Madison avenue partners, lp3.72M0.37%-394.15K

New Positions

HolderShares% AssetsChangeValue
Driehaus capital management1.40M0.01%1.40M$1.08M
Adage capital partners gp1.00M0.00%1.00M$933.70K
Sio capital management1.00M0.26%1.00M$933.70K
Velan capital investment management lp70.00K0.06%70.00K$65.36K
Susquehanna group, llp45.12K-45.12K$42.13K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-10.00
Qube research-54.00
Ica group wealth management-55.00
Capital performance advisors llp-146.00
Metropolitan life insurance co/ny-977.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202428-63.16%10,144,389-73.85%140.48%13-69.05%7-53.33%
Sep 30, 2024762.70%38,794,6550.78%541.84%4216.67%15-40.00%
Jun 30, 202474-8.64%38,492,740-9.60%541.50%36-5.26%254.17%
Mar 31, 2024815.19%42,579,420-3.51%601.55%38-7.32%2441.18%
Dec 31, 20237720.31%44,126,8774.21%621.73%4178.26%17-15.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.79M2.52%-
Vanguard US Total Market Shares ETF1.79M2.52%-
iShares Russell 2000 ETF1.64M2.31%-14.19K
Kennedy Micro Cap1.10M1.55%-3.90K
Vanguard Institutional Extnd Mkt Idx Tr819.59K1.15%-
Fidelity Small Cap Index579.52K0.82%-10.85K
State St Russell Sm/Mid Cp® Indx NL Cl C525.80K0.74%-
State St Russell Sm/Mid Cp® Indx SL Cl I525.80K0.74%-
iShares Russell 2000 Growth ETF516.23K0.73%-2.46K
MEDICAL BioHealth EUR Acc503.85K0.71%-

Recent Insider Transactions


DateNameRoleActivityValue
Feb 26, 2025ALEXANDER MARGARET A. President and COOSell$2.96K
Feb 26, 2025Rona Jeffrey A CBFOSell$2.19K
Jan 27, 2025ALEXANDER MARGARET A. President and COOBuy$4.97K
Mar 18, 2024LEVIN JEREMY M CEOBuy$50.36K
Sep 12, 2022Tardio Jason Chief Operating OfficerSell$37.29K

Insider Transactions Trends


DateBuySell
2025 Q112
2024 Q4--
2024 Q3--
2024 Q11-
2023 Q4--

OVID Ownership FAQ


Who Owns Ovid Therapeutics?

Ovid Therapeutics shareholders are primarily institutional investors at 14.29%, followed by 15.90% insiders and 69.81% retail investors. The average institutional ownership in Ovid Therapeutics's industry, Biotech Stocks , is 68.48%, which Ovid Therapeutics falls below.

Who owns the most shares of Ovid Therapeutics?

Ovid Therapeutics’s largest shareholders are Takeda pharmaceutical (7.53M shares, 10.61%), Rubric capital management lp (5.32M shares, 7.49%), and Blackrock (3.99M shares, 5.65%). Together, they hold 23.75% of Ovid Therapeutics’s total shares outstanding.

Does Blackrock own Ovid Therapeutics?

Yes, BlackRock owns 5.65% of Ovid Therapeutics, totaling 3.99M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 3.07M$. In the last quarter, BlackRock decreased its holdings by -203K shares, a -4.84% change.

Who is Ovid Therapeutics’s biggest shareholder by percentage of total assets invested?

Takeda pharmaceutical is Ovid Therapeutics’s biggest shareholder by percentage of total assets invested, with 26.40% of its assets in 7.53M Ovid Therapeutics shares, valued at 7.01M$.

Who is the top mutual fund holder of Ovid Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Ovid Therapeutics shares, with 2.52% of its total shares outstanding invested in 1.79M Ovid Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools